SNEHA SUNIL: Open Payments
NPI 1346836855 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$296 in 14 payments from 7 companies in 2025. Trend: 2023 $26 · 2024 $122 · 2025 $296
Food & beverage: $296
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $83 |
| Lilly USA, LLC | 3 | $59 |
| Janssen Biotech, Inc. | 2 | $53 |
| ABBVIE INC. | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
Products named: ENTYVIO, OMVOH, TREMFYA, LINZESS, VOQUEZNA, XIFAXAN, DUPIXENT, GATTEX.
Industry payments across FL — which companies pay providers there.
